Cross-fund · 5 holders
TSHA
TAYSHA GENE THERAPIES INC
CUSIP 877619106
5
Tracked holders
$174.1M
Aggregate value
35,883,924
Shares
5
Active funds
Funds holding TSHA
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $82.1M | — | -277,521 | -1.5% |
| Vanguard | Institutional | Q4 2025 | $73.0M | — | +418,192 | +3.3% |
| Millennium | Multi-Strategy | Q1 2026 | $14.7M | 0.01% | +102,957 | +3.2% |
| Citadel | Multi-Strategy | Q1 2026 | $2.3M | — | -1,449,620 | -74.1% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $2.1M | — | -3,406,826 | -88.1% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.